Virus therapy targets Hard-to-Treat melanoma in early trial
Disease control
Recruiting now
This early-stage study tests a new treatment called Adze1.C, a virus designed to infect and kill cancer cells while also boosting the immune system. It is for adults with advanced melanoma that has not responded to standard therapies. The main goals are to check the treatment's s…
Phase: PHASE1 • Sponsor: Adze Biotechnology Australia Pty Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC